◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sihuan Pharmaceutical Holdings Group Ltd. (0460) Financial History

Name: Sihuan Pharmaceutical Holdings Group Ltd. (0460) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Sihuan Pharmaceutical Holdings Group Ltd. (0460) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 2,843 employees. Its market capitalization is roughly CNY 8 billion. In the fiscal year ended 2025-12-31, 0460 reported CNY 2.6B in revenue and CNY 180M in net income.

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally.

Interactive charts & full statements →

0460 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 2.6B	CNY 1.9B	CNY 1.9B	CNY 2.2B	—
Gross Profit	CNY 1.8B	CNY 1.2B	CNY 1.3B	CNY 1.5B	—
Operating Income (EBIT)	CNY 375M	(CNY 462M)	(CNY 192M)	(CNY 554M)	—
Net Income	CNY 180M	(CNY 217M)	(CNY 54M)	(CNY 1.9B)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0460 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 91M)	(CNY 177M)	(CNY 299M)	(CNY 1.3B)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0460 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 11.6B	CNY 10.5B	CNY 11.5B	CNY 12.1B	—
Total Liabilities	CNY 4.7B	CNY 5.6B	CNY 6.4B	CNY 6.5B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0460 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

2627 · Ab&B Bio-Tech CO., LTD. JS — $12 billion
4524 · Morishita Jintan Co., Ltd. — $9 billion
4512 · Wakamoto Pharmaceutical Co.,Ltd. — $9 billion
2186 · Luye Pharma Group Ltd. — $8 billion
APTX · Apotex Health Corp. — $8 billion
0570 · China Traditional Chinese Medicine Holdings Co. Limited — $7 billion
2005 · SSY Group Limited — $7 billion
2575 · Xuanzhu Biopharmaceutical Co., Ltd. — $6 billion

← 0458 All “0-9” companies 0464 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.